Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP317043.RACVGsQ-YhQ4Fw_FBWh0poJNsc1n6Rj5ruigtsBsCFgc4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP317043.RACVGsQ-YhQ4Fw_FBWh0poJNsc1n6Rj5ruigtsBsCFgc4130_assertion type Assertion NP317043.RACVGsQ-YhQ4Fw_FBWh0poJNsc1n6Rj5ruigtsBsCFgc4130_head.
- NP317043.RACVGsQ-YhQ4Fw_FBWh0poJNsc1n6Rj5ruigtsBsCFgc4130_assertion wasGeneratedBy ECO_0000203 NP317043.RACVGsQ-YhQ4Fw_FBWh0poJNsc1n6Rj5ruigtsBsCFgc4130_provenance.
- NP317043.RACVGsQ-YhQ4Fw_FBWh0poJNsc1n6Rj5ruigtsBsCFgc4130_assertion wasDerivedFrom befree-2016 NP317043.RACVGsQ-YhQ4Fw_FBWh0poJNsc1n6Rj5ruigtsBsCFgc4130_provenance.
- NP317043.RACVGsQ-YhQ4Fw_FBWh0poJNsc1n6Rj5ruigtsBsCFgc4130_assertion SIO_000772 11340609 NP317043.RACVGsQ-YhQ4Fw_FBWh0poJNsc1n6Rj5ruigtsBsCFgc4130_provenance.
- NP317043.RACVGsQ-YhQ4Fw_FBWh0poJNsc1n6Rj5ruigtsBsCFgc4130_assertion evidence source_evidence_literature NP317043.RACVGsQ-YhQ4Fw_FBWh0poJNsc1n6Rj5ruigtsBsCFgc4130_provenance.
- NP317043.RACVGsQ-YhQ4Fw_FBWh0poJNsc1n6Rj5ruigtsBsCFgc4130_assertion description "[Patients with rare cancer predisposition syndromes including neurofibromatosis type 1 and inherited p53 mutations are at an increased risk for this complication.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP317043.RACVGsQ-YhQ4Fw_FBWh0poJNsc1n6Rj5ruigtsBsCFgc4130_provenance.